Baxter International (NYSE:BAX – Get Free Report) had its price objective dropped by analysts at JPMorgan Chase & Co. from ...

Key Takeaways Baxter International shares soared Thursday after the company's fourth-quarter results topped estimates.The ...

Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” ...

Baxter International Inc. closed 24.01% short of its 52-week high of $44.01, which the company reached on March 8th.

Shares of Baxter International (NYSE:BAX) traded higher in the premarket on Thursday after the medical product maker reported ...

The Deerfield, Illinois-based medtech company reported losses of $512 million. That equals $1 per share on sales of $2.75 ...

While being a session player can sometimes be a thankless job, Baxter recalls a particularly memorable session with Steely Dan producer Gary Katz ...

Following the completion of a massive restructuring plan, the medical equipment giant projects 4% to 5% sales growth this ...

Barclays began coverage on shares of Baxter International (NYSE:BAX – Free Report) in a report released on Thursday, Marketbeat reports. The brokerage issued an overweight rating and a $39.00 price ...

A Baxter International intravenous manufacturing plant in North Carolina is back up and running at full capacity after it ...

Barclays reinstated coverage of Baxter (BAX) with an Overweight rating and $39 price target The firm updated its sales projections to reflect ...

Shares of Baxter International on Thursday rose on pace for the largest percent increase since March 2020 after fourth-quarter sales and outlook for the first quarter and 2025 beat Wall Street ...